Kevin Michael  Mullins net worth and biography

Kevin Mullins Biography and Net Worth

Kevin has over 10 years of experience in healthcare, as both an operator and investor. He joined LifeStance Health in early 2017 and focuses acquiring and integrating new behavioral health practices.

Prior to joining LifeStance, Kevin was a Vice President at Summit Partners where he focused on investments in the healthcare services and life sciences sector. While at Summit, he was part of the team that founded MedSpring Urgent Care, which operates 50 urgent care centers in 3 states and was acquired by Fresenius Medical Care. Previously, Kevin worked at Curaspan and in the Healthcare Investment Banking Group at Leerink Partners. He holds a BA in physics and economics from Bowdoin College and a MBA from the Stanford Graduate School of Business.

Kevin enjoys listening to sports radio, CrossFit, biking and all Boston sports.

What is Kevin Michael Mullins' net worth?

The estimated net worth of Kevin Michael Mullins is at least $33.21 million as of June 11th, 2024. Mr. Mullins owns 4,650,571 shares of LifeStance Health Group stock worth more than $33,205,077 as of November 17th. This net worth estimate does not reflect any other assets that Mr. Mullins may own. Learn More about Kevin Michael Mullins' net worth.

How old is Kevin Michael Mullins?

Mr. Mullins is currently 38 years old. There are 7 older executives and no younger executives at LifeStance Health Group. The oldest executive at LifeStance Health Group is Mr. Kenneth Alan Burdick, CEO & Chairman, who is 65 years old. Learn More on Kevin Michael Mullins' age.

How do I contact Kevin Michael Mullins?

The corporate mailing address for Mr. Mullins and other LifeStance Health Group executives is , , . LifeStance Health Group can also be reached via phone at 602-767-2100 and via email at [email protected]. Learn More on Kevin Michael Mullins' contact information.

Has Kevin Michael Mullins been buying or selling shares of LifeStance Health Group?

Kevin Michael Mullins has not been actively trading shares of LifeStance Health Group during the last ninety days. Most recently, Kevin Michael Mullins sold 85,093 shares of the business's stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $5.53, for a transaction totalling $470,564.29. Following the completion of the sale, the insider now directly owns 4,650,571 shares of the company's stock, valued at $25,717,657.63. Learn More on Kevin Michael Mullins' trading history.

Who are LifeStance Health Group's active insiders?

LifeStance Health Group's insider roster includes David Bourdon (CFO), Jeffrey Crisan (Director), Kevin Mullins (Insider), Ryan Pardo (Chief Legal Officer), Anisha Patel-Dunn (Chief Medical Officer), Danish Qureshi (President and Chief Operating Officer), and Ann Varanakis (Chief People Officer). Learn More on LifeStance Health Group's active insiders.

Are insiders buying or selling shares of LifeStance Health Group?

In the last twelve months, insiders at the sold shares 13 times. They sold a total of 4,455,151 shares worth more than $26,596,704.06. The most recent insider tranaction occured on August, 23rd when insider Ann Varanakis sold 5,269 shares worth more than $33,089.32. Insiders at LifeStance Health Group own 6.6% of the company. Learn More about insider trades at LifeStance Health Group.

Information on this page was last updated on 8/23/2024.

Kevin Michael Mullins Insider Trading History at LifeStance Health Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/11/2024Sell85,093$5.53$470,564.294,650,571View SEC Filing Icon  
3/14/2024Sell44,540$6.33$281,938.204,745,352View SEC Filing Icon  
3/1/2024Sell115,136$8.02$923,390.724,575,480View SEC Filing Icon  
12/1/2023Sell113,334$6.54$741,204.364,690,616View SEC Filing Icon  
11/6/2023Sell300$6.12$1,836.004,836,006View SEC Filing Icon  
11/3/2023Sell80,977$6.13$496,389.014,836,306View SEC Filing Icon  
10/2/2023Sell113,333$6.61$749,131.134,917,283View SEC Filing Icon  
7/5/2023Sell150,000$8.72$1,308,000.005,166,016View SEC Filing Icon  
7/3/2023Sell54,600$9.00$491,400.005,316,016View SEC Filing Icon  
6/23/2023Sell65,832$9.02$593,804.645,370,616View SEC Filing Icon  
4/3/2023Sell97,266$7.43$722,686.385,512,581View SEC Filing Icon  
3/16/2023Sell43,705$6.14$268,348.705,609,847View SEC Filing Icon  
3/14/2023Sell800$6.11$4,888.005,653,752View SEC Filing Icon  
3/8/2023Sell122,295$6.12$748,445.405,654,552View SEC Filing Icon  
9/30/2022Sell82,520$7.03$580,115.605,584,540View SEC Filing Icon  
4/20/2022Sell46,283$10.68$494,302.445,669,472View SEC Filing Icon  
See Full Table

Kevin Michael Mullins Buying and Selling Activity at LifeStance Health Group

This chart shows Kevin Michael Mullins's buying and selling at LifeStance Health Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LifeStance Health Group Company Overview

LifeStance Health Group logo
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Read More

Today's Range

Now: $7.14
Low: $7.06
High: $7.29

50 Day Range

MA: $6.98
Low: $6.67
High: $7.68

2 Week Range

Now: $7.14
Low: $4.64
High: $9.20

Volume

1,009,023 shs

Average Volume

1,699,919 shs

Market Capitalization

$2.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24